Carcinoma Clinical Trials

Active, not recruiting

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

NCT06223568

Conditions: Cancer Vaccine, Carcinoma, Carcinoma, Squamous Cell, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

NCT03355976

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +28 more
Locations: University of Illinois Chicago Chicago, Illinois, United States

Rhode Island Hospital Providence, Rhode Island, United States

Women & Infants Hospital Providence, Rhode Island, United States

The Miriam Hospital Providence, Rhode Island, United States

View Trial Details

Active, not recruiting

Neuroendocrine Tumors - Patient Reported Outcomes

NCT05064150

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations: University of Florida Gainesville, Florida, United States

University of Iowa Iowa City, Iowa, United States

University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States

Regents of the University of Michigan Ann Arbor, Michigan, United States

View all 14 locations

View Trial Details

Active, not recruiting

AK117 (Anti-CD47 mAb) Plus Cetuximab or AK104 (Anti-PD-1/CTLA-4 bsAb) as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT06508606

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Active, not recruiting

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

NCT06084884

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Research Site Phoenix, Arizona, United States

Research Site Duarte, California, United States

Research Site Orange, California, United States

Research Site San Francisco, California, United States

View all 19 locations

View Trial Details

Active, not recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations: Clinical Trial Site Phoenix, Arizona, United States

Clinical Trial Site Phoenix, Arizona, United States

Clinical Trial Site New Haven, Connecticut, United States

Clinical Trial Site Tampa, Florida, United States

View all 14 locations

View Trial Details

Active, not recruiting

App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer

NCT04788095

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

NCT07160335

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations: Oncology Physicians Network (OPN) - Glendale Glendale, California, United States

Oncology Physicians Network (OPN)- Los Alamitos Los Alamitos, California, United States

HCA Los Angeles, California, United States

Los Angeles Cancer Network Los Angeles, California, United States

View all 69 locations

View Trial Details

Active, not recruiting

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

NCT03212274

Conditions: Adenocarcinoma, Advanced Malignant Solid Neoplasm, Astrocytoma, +16 more
Locations: UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States

View all 51 locations

View Trial Details

Active, not recruiting

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

NCT06564844

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations: Research Site Tucson, Arizona, United States

Research Site Duarte, California, United States

Research Site Glendale, California, United States

Research Site Los Angeles, California, United States

View all 90 locations

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions